TransMedics Group Inc. TMDX
Super Investor & Insider
1
Fondi che lo detengono
#1389
Rank consenso
1.4%
% dei portafogli
$737,821
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.01% | Reduce 31.46% | 7,422 | $737,821 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
TransMedics Group Inc. is a commercial-stage medical technology company focused on advancing organ transplant therapy for patients with end-stage organ failure. It develops and commercializes the Organ Care System (OCS), a portable platform that preserves, optimizes, and monitors donor organs in near-physiologic condit…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees898
TickerTMDX
Statistics
Market Cap$2.53B
Revenue (TTM)$605.5M
Net Income$190.3M
Net Margin31.4%
EPS$4.87
P/E16.84
P/S4.00
P/B5.33
EV/EBITDA23.50
ROE45.2%
Dividend Yield—
Price$73.16
Data: Twelve Data · Revenue = mcap / P/S